CN108095125A - 一种保肝护肝的鮸鱼鱼鳔多肽保健食品及其制备方法 - Google Patents
一种保肝护肝的鮸鱼鱼鳔多肽保健食品及其制备方法 Download PDFInfo
- Publication number
- CN108095125A CN108095125A CN201711317125.7A CN201711317125A CN108095125A CN 108095125 A CN108095125 A CN 108095125A CN 201711317125 A CN201711317125 A CN 201711317125A CN 108095125 A CN108095125 A CN 108095125A
- Authority
- CN
- China
- Prior art keywords
- air bladder
- brown croaker
- polypeptide
- health care
- bladder polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004712 air sac Anatomy 0.000 title claims abstract description 136
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 112
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 110
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 103
- 241001417494 Sciaenidae Species 0.000 title claims abstract description 92
- 235000013305 food Nutrition 0.000 title claims abstract description 53
- 230000036541 health Effects 0.000 title claims abstract description 51
- 210000004185 liver Anatomy 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 38
- 230000002633 protecting effect Effects 0.000 title claims abstract description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 172
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 35
- 239000012153 distilled water Substances 0.000 claims abstract description 33
- 235000017276 Salvia Nutrition 0.000 claims abstract description 23
- 229930003231 vitamin Natural products 0.000 claims abstract description 23
- 235000013343 vitamin Nutrition 0.000 claims abstract description 23
- 239000011782 vitamin Substances 0.000 claims abstract description 23
- 229940088594 vitamin Drugs 0.000 claims abstract description 23
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 18
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims abstract description 16
- 150000002515 isoflavone derivatives Chemical class 0.000 claims abstract description 16
- 235000008696 isoflavones Nutrition 0.000 claims abstract description 16
- 239000002775 capsule Substances 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 11
- 235000013402 health food Nutrition 0.000 claims abstract description 7
- 238000001694 spray drying Methods 0.000 claims abstract description 6
- 241001072909 Salvia Species 0.000 claims abstract 4
- 235000019441 ethanol Nutrition 0.000 claims description 60
- 239000007788 liquid Substances 0.000 claims description 54
- 240000007164 Salvia officinalis Species 0.000 claims description 31
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 28
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- 102000004190 Enzymes Human genes 0.000 claims description 23
- 108090000790 Enzymes Proteins 0.000 claims description 23
- 239000011347 resin Substances 0.000 claims description 19
- 229920005989 resin Polymers 0.000 claims description 19
- 108091005804 Peptidases Proteins 0.000 claims description 17
- 239000004365 Protease Substances 0.000 claims description 17
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 17
- 239000003513 alkali Substances 0.000 claims description 17
- 238000005238 degreasing Methods 0.000 claims description 14
- 239000000047 product Substances 0.000 claims description 13
- 235000005412 red sage Nutrition 0.000 claims description 12
- 238000000108 ultra-filtration Methods 0.000 claims description 12
- 239000003480 eluent Substances 0.000 claims description 11
- 150000005693 branched-chain amino acids Chemical class 0.000 claims description 8
- 238000010612 desalination reaction Methods 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 238000004587 chromatography analysis Methods 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 241000251468 Actinopterygii Species 0.000 claims description 6
- CIWBSHSKHKDKBQ-MVHIGOERSA-N D-ascorbic acid Chemical compound OC[C@@H](O)[C@@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-MVHIGOERSA-N 0.000 claims description 6
- 229930003270 Vitamin B Natural products 0.000 claims description 6
- -1 aromatic amino acid Chemical class 0.000 claims description 6
- 230000009849 deactivation Effects 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000007689 inspection Methods 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000002137 ultrasound extraction Methods 0.000 claims description 6
- 235000019156 vitamin B Nutrition 0.000 claims description 6
- 239000011720 vitamin B Substances 0.000 claims description 6
- 238000011049 filling Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 241000252335 Acipenser Species 0.000 claims description 4
- 241001233037 catfish Species 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 2
- 238000002386 leaching Methods 0.000 claims description 2
- 241000961009 Miichthys Species 0.000 claims 1
- 230000007935 neutral effect Effects 0.000 claims 1
- 239000008188 pellet Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 36
- 208000019423 liver disease Diseases 0.000 abstract description 10
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 230000002980 postoperative effect Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 46
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- 235000019419 proteases Nutrition 0.000 description 14
- 230000006870 function Effects 0.000 description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 7
- 229930003268 Vitamin C Natural products 0.000 description 7
- 235000019154 vitamin C Nutrition 0.000 description 7
- 239000011718 vitamin C Substances 0.000 description 7
- 241000961010 Miichthys miiuy Species 0.000 description 6
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 description 6
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 6
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 5
- 102000002322 Egg Proteins Human genes 0.000 description 5
- 108010000912 Egg Proteins Proteins 0.000 description 5
- 235000014103 egg white Nutrition 0.000 description 5
- 210000000969 egg white Anatomy 0.000 description 5
- 235000011090 malic acid Nutrition 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 239000004833 fish glue Substances 0.000 description 4
- 239000007986 glycine-NaOH buffer Substances 0.000 description 4
- 230000002440 hepatic effect Effects 0.000 description 4
- 210000005229 liver cell Anatomy 0.000 description 4
- 238000003998 size exclusion chromatography high performance liquid chromatography Methods 0.000 description 4
- 238000010025 steaming Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 description 3
- 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- BJEPYKJPYRNKOW-UWTATZPHSA-N (R)-malic acid Chemical compound OC(=O)[C@H](O)CC(O)=O BJEPYKJPYRNKOW-UWTATZPHSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- HYXITZLLTYIPOF-UHFFFAOYSA-N Tanshinone II Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)=CO2 HYXITZLLTYIPOF-UHFFFAOYSA-N 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 210000004024 hepatic stellate cell Anatomy 0.000 description 2
- 210000005228 liver tissue Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- AZEZEAABTDXEHR-UHFFFAOYSA-M sodium;1,6,6-trimethyl-10,11-dioxo-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-2-sulfonate Chemical compound [Na+].C12=CC=C(C(CCC3)(C)C)C3=C2C(=O)C(=O)C2=C1OC(S([O-])(=O)=O)=C2C AZEZEAABTDXEHR-UHFFFAOYSA-M 0.000 description 2
- GDSOZVZXVXTJMI-SNAWJCMRSA-N (e)-1-methylbut-1-ene-1,2,4-tricarboxylic acid Chemical compound OC(=O)C(/C)=C(C(O)=O)\CCC(O)=O GDSOZVZXVXTJMI-SNAWJCMRSA-N 0.000 description 1
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- GVKKJJOMQCNPGB-JTQLQIEISA-N Cryptotanshinone Chemical compound O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1[C@@H](C)CO2 GVKKJJOMQCNPGB-JTQLQIEISA-N 0.000 description 1
- GVKKJJOMQCNPGB-UHFFFAOYSA-N Cryptotanshinone Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)CO2 GVKKJJOMQCNPGB-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000276569 Oryzias latipes Species 0.000 description 1
- 241000276618 Perciformes Species 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 231100000012 chronic liver injury Toxicity 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000021393 food security Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 230000002061 histotrophic effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000002445 liver protective agent Substances 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 229930015582 oxymatrine Natural products 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 229960004245 silymarin Drugs 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 239000010454 slate Substances 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/04—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from fish or other sea animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Marine Sciences & Fisheries (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711317125.7A CN108095125B (zh) | 2017-12-12 | 2017-12-12 | 一种保肝护肝的鮸鱼鱼鳔多肽保健食品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711317125.7A CN108095125B (zh) | 2017-12-12 | 2017-12-12 | 一种保肝护肝的鮸鱼鱼鳔多肽保健食品及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108095125A true CN108095125A (zh) | 2018-06-01 |
CN108095125B CN108095125B (zh) | 2021-05-18 |
Family
ID=62215592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711317125.7A Active CN108095125B (zh) | 2017-12-12 | 2017-12-12 | 一种保肝护肝的鮸鱼鱼鳔多肽保健食品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108095125B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105219827A (zh) * | 2015-11-10 | 2016-01-06 | 浙江海洋学院 | 鱼鳔胶原蛋白多功能肽的制备方法 |
CN105624247A (zh) * | 2016-02-29 | 2016-06-01 | 浙江海洋学院 | 一种金枪鱼高F值寡肽中的Nrf2-ARE通路激活剂的制备方法 |
CN105998578A (zh) * | 2016-07-22 | 2016-10-12 | 赵月 | 一种用于护肝的组合物 |
CN107114775A (zh) * | 2017-05-10 | 2017-09-01 | 浙江海洋大学 | 一种基于鮸鱼鱼鳔多肽的降血脂复配物及其制备方法 |
CN107212420A (zh) * | 2017-05-04 | 2017-09-29 | 浙江海洋大学 | 一种增强免疫能力的鲟鱼鱼鳔多肽保健食品及其制备方法 |
-
2017
- 2017-12-12 CN CN201711317125.7A patent/CN108095125B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105219827A (zh) * | 2015-11-10 | 2016-01-06 | 浙江海洋学院 | 鱼鳔胶原蛋白多功能肽的制备方法 |
CN105624247A (zh) * | 2016-02-29 | 2016-06-01 | 浙江海洋学院 | 一种金枪鱼高F值寡肽中的Nrf2-ARE通路激活剂的制备方法 |
CN105998578A (zh) * | 2016-07-22 | 2016-10-12 | 赵月 | 一种用于护肝的组合物 |
CN107212420A (zh) * | 2017-05-04 | 2017-09-29 | 浙江海洋大学 | 一种增强免疫能力的鲟鱼鱼鳔多肽保健食品及其制备方法 |
CN107114775A (zh) * | 2017-05-10 | 2017-09-01 | 浙江海洋大学 | 一种基于鮸鱼鱼鳔多肽的降血脂复配物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN108095125B (zh) | 2021-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107296949A (zh) | 药食同源复合制剂及其制备方法和应用 | |
CN105054003A (zh) | 一种有助于预防和缓解老年人肌肉萎缩的保健食品 | |
KR101627837B1 (ko) | 말뼈 추출물과 해마를 주성분으로 포함하는 건강보조식품 및 그의 제조방법 | |
CN101081239A (zh) | 一种灵芝糖肽及其制造方法 | |
CN102068494A (zh) | 对化学性肝损伤有治疗作用的保健胶囊及其制备方法 | |
CN110916200A (zh) | 一种降尿酸组合物及其制备方法 | |
US9861664B2 (en) | Traditional chinese medicine complex composite for significantly improving high density lipoprotein concentration in serum and preparation method thereof | |
KR20100067575A (ko) | 해조류 매생이를 함유하는 공진환의 제조 | |
CN101185706B (zh) | 具有延缓衰老作用的沙棘营养复合剂及其制备工艺 | |
KR20130009901A (ko) | 혈행개선 및 기력보강과 골다공증 예방을 위한 건강식품 조성물 | |
CN107184621A (zh) | 一种辣木叶有效成分的提取方法及其应用 | |
CN108095125A (zh) | 一种保肝护肝的鮸鱼鱼鳔多肽保健食品及其制备方法 | |
CN110693025A (zh) | 一种多功能成分协同降血糖的组合物及其应用 | |
CN109043055A (zh) | 一种改善亚健康状态的凉茶 | |
CN1060028C (zh) | 一种主要由谷物瓜菜果组成的健康食品 | |
KR20110121246A (ko) | 비만개선 다이어트용 웰빙 한방식품 및 그 제조방법 | |
CN101411499B (zh) | 大蒜、洋葱复合精油与抗氧化剂维生素类复配软胶囊 | |
CN108355128A (zh) | 一种牡蛎肽虫草素制品 | |
CN114642236A (zh) | 一种可以辅助降血压的小球藻纳豆压片糖果 | |
CN101129418B (zh) | 一种含鸡枞菌和绿菇菌的复方制剂 | |
CN102872198A (zh) | 一种保肝胶囊及其制备方法 | |
CN1679701A (zh) | 一种由三七、红花制成的治疗心脑血管疾病的药物制剂及其制备方法 | |
CN113633719A (zh) | 一种抗氧化组合物及制备方法、应用 | |
CN110090249A (zh) | 预防和治疗高血压的中药组合物及其制备方法与应用 | |
CN106165894A (zh) | 一种冲调即食型多种食用菌复合营养粉及其生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220620 Address after: 710000 No. B49, Xinda Zhongchuang space, 26th Street, block C, No. 2 Trading Plaza, South China City, international port district, Xi'an, Shaanxi Province Patentee after: Xi'an Huaqi Zhongxin Technology Development Co.,Ltd. Address before: 316000 No. 1, Haida South Road, Changzhi Island, Lincheng street, Dinghai District, Zhoushan, Zhejiang. Patentee before: Zhejiang Ocean University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230324 Address after: No.138, South Zhaoyang Road, Rizhao Economic Development Zone, Shandong Province Patentee after: Tekang Pharmaceutical Group Co.,Ltd. Address before: 710000 No. B49, Xinda Zhongchuang space, 26th Street, block C, No. 2 Trading Plaza, South China City, international port district, Xi'an, Shaanxi Province Patentee before: Xi'an Huaqi Zhongxin Technology Development Co.,Ltd. |
|
TR01 | Transfer of patent right |